ClinicalTrials.Veeva

Menu

Genetic Analysis of Thyrotoxic Periodic Paralysis

M

Mahidol University

Status

Completed

Conditions

Thyrotoxic Periodic Paralysis

Study type

Observational

Funder types

Other

Identifiers

NCT00443833
11-46-21

Details and patient eligibility

About

Thyrotoxic periodic paralysis (TPP) is characterized by episodes of reversible hypokalemia and weakness in thyrotoxic patients. It is commonly found in males of Asian descent and is also seen in individuals having Native American or Hispanic ancestry. Therefore genetic etiology has been hypothesized. This study, we aim to find the susceptibility genes that associate with TPP. Both candidate genes approach and genome wide association study have been conducted.

Full description

This study is a genetic association study. It included 50 cases of TPP patients and 80 cases of male, hyperthyroid patients who didn't have hypokalemia as a well characterized controls. After informed consent were obtained, genomic DNA from leukocyte were extracted. Pooled DNA were constructed and whole genome scan using 10K GeneChip microarray were genotyped on pooled genomic DNA.

Sex

Male

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

TPP

  • Hyperthyroid patients from any causes
  • Evidence of hypokalemia (k<3.5 mg/dl)from intracellular shift (Urine K<15 mg/dl, TTKG<2)
  • Episodic paralysis

Exclusion criteria

  • Hypokalemia from GI or renal loss

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems